Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?
- 1 November 1986
- Vol. 293 (6555) , 1117-1118
- https://doi.org/10.1136/bmj.293.6555.1117
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Augmented Postprandial Gastric Acid Secretion Due to Exposure to Ranitidine in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.Gut, 1986
- THE CHOICE OF ULCER HEALING AGENT INFLUENCES DUODENAL ULCER RELAPSE RATE AND LONG‐TERM CLINICAL OUTCOMEAustralian and New Zealand Journal of Medicine, 1985
- RELAPSE OF DUODENAL ULCERS AFTER CIMETIDINE TREATMENT: IDOL ‘INDECENTLY’ ASSAULTED?Australian and New Zealand Journal of Medicine, 1985
- Duodenal ulcers that will not heal.Gut, 1984
- Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.Gut, 1983
- Relapse Rates after Initial Ulcer Healing with Sucralfate and CimetidineScandinavian Journal of Gastroenterology, 1982
- Cimetidine and Colloidal Bismuth in Treatment of Chronic Duodenal UlcerDigestion, 1982
- DIFFERENCE IN RELAPSE RATES OF DUODENAL ULCER AFTER HEALING WITH CIMETIDINE OR TRIPOTASSIUM DICITRATO BISMUTHATEThe Lancet, 1981
- Long-term cimetidine in duodenal ulcer diseaseDigestive Diseases and Sciences, 1979